148 related articles for article (PubMed ID: 29725387)
1. PF-2341066 combined with celecoxib promotes apoptosis and inhibits proliferation in human cholangiocarcinoma QBC939 cells.
Chen C; Yang D; Zeng Q; Luo L; Cai C
Exp Ther Med; 2018 May; 15(5):4543-4549. PubMed ID: 29725387
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E2 pathway in human cholangiocarcinoma cell lines.
Wu GS; Zou SQ; Liu ZR; Tang ZH; Wang JH
World J Gastroenterol; 2003 Jun; 9(6):1302-6. PubMed ID: 12800245
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21waf1/cip1 and p27kip1 and cell cycle arrest.
Han C; Leng J; Demetris AJ; Wu T
Cancer Res; 2004 Feb; 64(4):1369-76. PubMed ID: 14973068
[TBL] [Abstract][Full Text] [Related]
4. Influence of Photodynamic Therapy on Apoptosis and Invasion of Human Cholangiocarcinoma QBC939 Cell Line.
Chen YJ; Jiang HT; Cao JY
Chin Med Sci J; 2015 Dec; 30(4):252-9. PubMed ID: 26960307
[TBL] [Abstract][Full Text] [Related]
5. The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells.
Wu T; Leng J; Han C; Demetris AJ
Mol Cancer Ther; 2004 Mar; 3(3):299-307. PubMed ID: 15026550
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of nerve growth factor-β in human cholangiocarcinoma QBC939 cells promote tumor progression.
Yue XJ; Xu LB; Zhu MS; Zhang R; Liu C
PLoS One; 2013; 8(4):e62024. PubMed ID: 23637956
[TBL] [Abstract][Full Text] [Related]
7. Brucine suppresses proliferation and promotes apoptosis of human cholangiacarcinoma cells via the inhibition of COX2 expression.
Kang Q; Zheng K; Jiang GM; Li YK; Liang YB; Geng Q; Qian CH; Wang QB; He ZY; Huang SQ; Yang C; Li J; Li YH; Ke Y
J Cancer; 2023; 14(14):2700-2706. PubMed ID: 37779869
[No Abstract] [Full Text] [Related]
8. Effects of cyclooxygenase-2 antisense vector on proliferation of human cholangiocarcinoma cells.
Wu GS; Zou SQ; Wu XY; Qiu FZ
Chin Med Sci J; 2004 Jun; 19(2):89-92. PubMed ID: 15250241
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation.
Zhang Z; Lai GH; Sirica AE
Hepatology; 2004 Apr; 39(4):1028-37. PubMed ID: 15057907
[TBL] [Abstract][Full Text] [Related]
10. Reappraisal of the therapeutic role of celecoxib in cholangiocarcinoma.
Yeh CN; Chiang KC; Juang HH; S Pang JH; Yu CS; Lin KJ; Yeh TS; Jan YY
PLoS One; 2013; 8(7):e69928. PubMed ID: 23922859
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts.
Raut CP; Nawrocki S; Lashinger LM; Davis DW; Khanbolooki S; Xiong H; Ellis LM; McConkey DJ
Cancer Biol Ther; 2004 Dec; 3(12):1217-24. PubMed ID: 15477758
[TBL] [Abstract][Full Text] [Related]
12. Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum.
Ninomiya I; Nagai N; Oyama K; Hayashi H; Tajima H; Kitagawa H; Fushida S; Fujimura T; Ohta T
Oncol Rep; 2012 Sep; 28(3):777-84. PubMed ID: 22751903
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions.
Majumder M; Xin X; Liu L; Girish GV; Lala PK
Cancer Sci; 2014 Sep; 105(9):1142-51. PubMed ID: 24981602
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
Wang L; Chen W; Xie X; He Y; Bai X
Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
[TBL] [Abstract][Full Text] [Related]
15. Effect of celecoxib combined with chemotherapy drug on malignant biological behaviors of gastric cancer.
Meng C; Lu Z; Fang M; Zhou X; Dai K; Zhang S; Luo J; Luo Z
Int J Clin Exp Pathol; 2014; 7(11):7622-32. PubMed ID: 25550798
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib acts in a cyclooxygenase-2-independent manner and in synergy with emodin to suppress rat cholangiocarcinoma growth in vitro through a mechanism involving enhanced Akt inactivation and increased activation of caspases-9 and -3.
Lai GH; Zhang Z; Sirica AE
Mol Cancer Ther; 2003 Mar; 2(3):265-71. PubMed ID: 12657721
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis.
Liu NB; Peng T; Pan C; Yao YY; Shen B; Leng J
World J Gastroenterol; 2005 Oct; 11(40):6281-7. PubMed ID: 16419156
[TBL] [Abstract][Full Text] [Related]
19. Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: novel strategies for colon cancer prevention and treatment.
Swamy MV; Cooma I; Patlolla JM; Simi B; Reddy BS; Rao CV
Mol Cancer Ther; 2004 Feb; 3(2):215-21. PubMed ID: 14985462
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting the proliferation and metastasis of hilar cholangiocarcinoma cells by blocking the expression of vascular endothelial growth factor with small interfering RNA.
Xiao K; Ouyang Z; Tang HH
Oncol Lett; 2018 Aug; 16(2):1841-1848. PubMed ID: 30008874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
